Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000947871-24-000581
Filing Date
2024-06-28
Accepted
2024-06-28 17:37:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3742
  Complete submission text file 0000947871-24-000581.txt   5417
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: 144

Mailing Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355 484-320-2930
TELA Bio, Inc. (Subject) CIK: 0001561921 (see all company filings)

EIN.: 455320061 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39130 | Film No.: 241087127
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)